Cardiovascular Benefits of Aldosterone Receptor Antagonists: What About Potassium?

Hypertension - United States
doi 10.1161/01.hyp.0000174329.99569.52
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Cardiovascular Effects of Aldosterone: Insight From Adult Carriers of Mineralocorticoid Receptor Mutations

Circulation: Cardiovascular Genetics
2013English

SK Potassium Channel Antagonists as Novel Bronchodilators

Journal of Allergy and Clinical Immunology
AllergyImmunology
2016English

Retinoid X Receptor Antagonists

2018English

Optimizing Cardiovascular and Chemopreventive Benefits of Aspirin: What Role for the Proton-Pump Inhibitors?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2005English

Third-Generation Mineralocorticoid Receptor Antagonists

Journal of Cardiovascular Pharmacology
Cardiovascular MedicinePharmacologyCardiology
2016English

Response to Letter to the Editor: Effects of New Antiplatelet Agents and Aldosterone Receptor Antagonists on Mortality in Patients With Myocardial Infarction

Cardiovascular Drugs and Therapy
MedicineCardiovascular MedicinePharmacologyCardiology
2015English

Corticotropin-Releasing Hormone Receptor Antagonists

European Journal of Endocrinology
MedicineEndocrinologyMetabolismDiabetes
2006English

Renal Potassium Wasting in Distal Renal Tubular Acidosis: Role of Aldosterone.

Internal Medicine
Internal MedicineMedicine
1992English

The North Karelia Project: What It Tells Us About the Prevention of Cardiovascular Disease.

American Journal of Public Health
EnvironmentalPublic HealthOccupational Health
1982English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy